This is an old revision of this page, as edited by Beetstra (talk | contribs) at 15:23, 4 November 2011 (Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'DrugBank', 'ChEBI', 'StdInChI', 'StdInChIKey', 'CAS_number').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 15:23, 4 November 2011 by Beetstra (talk | contribs) (Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'DrugBank', 'ChEBI', 'StdInChI', 'StdInChIKey', 'CAS_number').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compoundClinical data | |
---|---|
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Routes of administration | Oral |
ATC code | |
Pharmacokinetic data | |
Metabolism | Rapidly hydrolyzed to ampicillin |
Identifiers | |
IUPAC name
| |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C21H27N3O7S |
Molar mass | 465.519 g/mol g·mol |
InChI
| |
(what is this?) (verify) |
Bacampicillin (INN) is a penicillin antibiotic. It is a prodrug of ampicillin with improved oral bioavailability.
It is sold under the brand names Spectrobid (Pfizer) and Penglobe (AstraZeneca).
References
- Bodin NO; Ekström B; Forsgren U; et al. (1975). "Bacampicillin: a New Orally Well-Absorbed Derivative of Ampicillin". Antimicrob Agents Chemother. 8 (5): 518–25. PMC 429411. PMID 1211909.
{{cite journal}}
: Unknown parameter|author-separator=
ignored (help); Unknown parameter|month=
ignored (help)
This systemic antibiotic-related article is a stub. You can help Misplaced Pages by expanding it. |